ArborGen Holdings

No forward-work, guidance, or quantitative targets were supplied. The one shape signal — HY25 being just 20.9% of full-year revenue — confirms a heavily second-half-weighted business (consistent with the cone-harvest and seedling seasonality referenced in the HY context). That seasonality normally argues for a strong H2, so the fact that H2 carried the entire NZ$21.4m loss despite NZ$50m of revenue is the key anomaly a reader should want explained. The release as supplied does not support any view on FY26 recovery; it documents a deterioration but not its cause or persistence.

• What drove the H2 step-down: impairment, inventory write-down, pricing, or volume shortfall? The supplied excerpts do not identify the specific line item.
• Why tax expense remained positive against a large pre-tax loss — is deferred-tax asset recognition being restricted?
• Inventory days of 311.7 on a NZ$38.4m book: is any of this at risk of write-down in FY26?
• Covenant headroom and committed facility size given gross debt rose to NZ$24.4m against only NZ$3.5m of cash.
• Whether management has signalled any cost, capex, or capital-structure response — none is disclosed in the supplied material.

This briefing cannot assess the operational cause of the H2 loss, management's outlook, or covenant/liquidity adequacy, because none of those are contained in the supplied extraction data.